Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The functional heart is comprised of distinct mesoderm-derived lineages including cardiomyocytes, endothelial cells and vascular smooth muscle cells. Studies in the mouse embryo and the mouse embryonic stem cell differentiation model have provided evidence indicating that these three lineages develop from a common Flk-1(+) (kinase insert domain protein receptor, also known as Kdr) cardiovascular progenitor that represents one of the earliest stages in mesoderm specification to the cardiovascular lineages. To determine whether a comparable progenitor is present during human cardiogenesis, we analysed the development of the cardiovascular lineages in human embryonic stem cell differentiation cultures. Here we show that after induction with combinations of activin A, bone morphogenetic protein 4 (BMP4), basic fibroblast growth factor (bFGF, also known as FGF2), vascular endothelial growth factor (VEGF, also known as VEGFA) and dickkopf homolog 1 (DKK1) in serum-free media, human embryonic-stem-cell-derived embryoid bodies generate a KDR(low)/C-KIT(CD117)(neg) population that displays cardiac, endothelial and vascular smooth muscle potential in vitro and, after transplantation, in vivo. When plated in monolayer cultures, these KDR(low)/C-KIT(neg) cells differentiate to generate populations consisting of greater than 50% contracting cardiomyocytes. Populations derived from the KDR(low)/C-KIT(neg) fraction give rise to colonies that contain all three lineages when plated in methylcellulose cultures. Results from limiting dilution studies and cell-mixing experiments support the interpretation that these colonies are clones, indicating that they develop from a cardiovascular colony-forming cell. Together, these findings identify a human cardiovascular progenitor that defines one of the earliest stages of human cardiac development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CMs can reliably be derived from human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) using protocols that involve timed application of GFs or small molecules, that are designed to recapitulate developmental pathways.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [148]
Citations
Cites
Laflamme, M. A., Chen, K. Y., Naumova, A. V., Muskheli, V., Fugate, J. A., Dupras, S. K., Reinecke, H., Xu, C., Hassanipour, M., Police, S., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1327 · Cited by 2,206
Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse.
Winnier, G., Blessing, M., Labosky, P. A., & Hogan, B. L. (1995) · Genes & Development · doi:10.1101/gad.9.17.2105 · Cited by 1,788
Cai, C.-L., Liang, X., Shi, Y., Chu, P.-H., Pfaff, S. L., Chen, J., & Evans, S. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00363-0 · Cited by 1,610
Moretti, A., Caron, L., Nakano, A., Lam, J. T., Bernshausen, A., Chen, Y., Qyang, Y., Bu, L., Sasaki, M., Martin-Puig, S., et al. (2006) · Cell · doi:10.1016/j.cell.2006.10.029 · Cited by 1,038
Bearzi, C., Rota, M., Hosoda, T., Tillmanns, J., Nascimbene, A., De Angelis, A., Yasuzawa-Amano, S., Trofimova, I., Siggins, R. W., LeCapitaine, N., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706760104 · Cited by 980
Requirement for Wnt3 in vertebrate axis formation
Liu, P., Wakamiya, M., Shea, M. J., Albrecht, U., Behringer, R. R., & Bradley, A. (1999) · Nature Genetics · doi:10.1038/11932 · Cited by 901
Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I., & Harvey, R. P. (1993) · Development · doi:10.1242/dev.119.2.419 · Cited by 861
Conlon, F. L., Lyons, K. M., Takaesu, N., Barth, K. S., Kispert, A., Herrmann, B., & Robertson, E. J. (1994) · Development · doi:10.1242/dev.120.7.1919 · Cited by 770
Kattman, S. J., Huber, T. L., & Keller, G. M. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.002 · Cited by 729
Self-citationRole of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum
de la Pompa, J. L., Timmerman, L. A., Takimoto, H., Yoshida, H., Elia, A. J., Samper, E., Potter, J., Wakeham, A., Marengere, L., Langille, B. L., et al. (1998) · Nature · doi:10.1038/32419 · Cited by 660
Cited by
Items 201–300 of 1,000
Drukker, M., Tang, C., Ardehali, R., Rinkevich, Y., Seita, J., Lee, A. S., Mosley, A. R., Weissman, I. L., & Soen, Y. (2012) · Nature Biotechnology · doi:10.1038/nbt.2239 · Cited by 114
Fernandes, S., Chong, J. J. H., Paige, S. L., Iwata, M., Torok‐Storb, B., Keller, G. M., Reinecke, H., & Murry, C. E. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.09.011 · Cited by 117
“On day 5 of differentiation (at the time of the injection procedure), hESC-CVP preparations contained 74% ± 4% tripotential cardiovascular progenitor (from 57% to 92%, identified by flow cytometry based on expression of KDR and PDGFRa; Figure 1B) (Yang et al., 2008).”
BackgroundMethodInfluentialSelf-citationMoretti, A., Bellin, M., Jung, C. B., Thies, T., Takashima, Y., Bernshausen, A., Schiemann, M., Fischer, S., Moosmang, S., Smith, A. G., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-139477 · Cited by 124
Buccini, S., Haider, K. H., Ahmed, R. P. H., Jiang, S., & Ashraf, M. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-012-0301-5 · Cited by 116
“For example, purification of cardiac progenitors based on surface markers and their differentiation to cardiac-like cells may enhance their cardiogenic potential without tumorigenicity [42].”
BackgroundYang, B., Yao, F., Hao, T., Fang, W., Ye, L., Zhang, Y., Wang, Y., Li, J., & Wang, C. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500520 · Cited by 116
Mazzotta, S., Neves, C., Bonner, R. J., Bernardo, A. S., Docherty, K., & Hoppler, S. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.08.008 · Cited by 128
“…et al., 2014; Karakikes et al., 2014; Kattman et al., 2011; Kempf et al., 2014; Lian et al., 2012; Otsuji et al., 2014; Paige et al., 2010; Phillips et al., 2008; Ting et al., 2014; Yang et al., 2008; Zhang et al., 2015), suggesting important roles for WNT signaling also in human heart development.”
BackgroundPark, S.-W., Koh, Y. J., Jeon, J., Cho, Y.-H., Jang, M.-J., Kang, Y., Kim, M., Choi, C., Cho, Y. S., Chung, H., et al. (2010) · Blood · doi:10.1182/blood-2010-04-280719 · Cited by 116
Cardiac Regeneration and Stem Cells
Zhang, Y., Mignone, J., & MacLellan, W. R. (2015) · Physiological Reviews · doi:10.1152/physrev.00021.2014 · Cited by 122
“These cardiac myocytes, while contractile, likely represent an immature developmental stage as they could be passaged and expanded in culture for some time (52, 127).”
BackgroundMaterials Science and Tissue Engineering: Repairing the Heart
Radisic, M., & Christman, K. L. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.05.003 · Cited by 133
Functional Cardiac Tissue Engineering
Liau, B., Zhang, D., & Bursac, N. (2012) · Regenerative Medicine · doi:10.2217/rme.11.122 · Cited by 105
Small molecules for reprogramming and transdifferentiation
Qin, H., Zhao, A., & Fu, X. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2586-x · Cited by 119
Empowering Adult Stem Cells for Myocardial Regeneration
Mohsin, S., Siddiqi, S., Collins, B. L., & Sussman, M. A. (2011) · Circulation Research · doi:10.1161/circresaha.111.243071 · Cited by 115
Smith, A. J., Lewis, F., Aquila, I., Waring, C. D., Nocera, A., Agosti, V., Nadal‐Ginard, B., Torella, D., & Ellison, G. M. (2014) · Nature Protocols · doi:10.1038/nprot.2014.113 · Cited by 111
ADDME – Avoiding Drug Development Mistakes Early: central nervous system drug discovery perspective
Tsaioun, K., Bottlaender, M., Mabondzo, A., & the Alzheimer's Drug Discovery Foundation (2009) · BMC Neurology · doi:10.1186/1471-2377-9-s1-s1 · Cited by 103
“The potential of stem cells to differentiate into cell lines of many different lineages may be exploited to develop human and animal stem-cell-derived systems for major organ systems [45].”
BackgroundMechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells
Kim, J. J., Yang, L., Lin, B., Zhu, X., Sun, B., Kaplan, A. D., Bett, G. C. L., Rasmusson, R. L., London, B., & Salama, G. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.013 · Cited by 108
“The following conditions were used for cardiomyocyte differentiation [30] from Y1 iPSCs by forming EBs using the basal StemPro®-34 medium (Invitrogen) as described in our previous studies [29,30]: days 0–1, BMP4 (5 ng/ml); days 1–4, BMP4 (10 ng/ml), bFGF (5 ng/ml) and Activin (1.”
MethodSelf-citationParikh, A., Patel, D. R., McTiernan, C. F., Xiang, W., Haney, J., Yang, L., Lin, B., Kaplan, A. D., Bett, G. C. L., Rasmusson, R. L., et al. (2013) · Circulation Research · doi:10.1161/circresaha.113.301646 · Cited by 113
Self-citationStepwise Clearance of Repressive Roadblocks Drives Cardiac Induction in Human ESCs
Rao, J., Pfeiffer, M. J., Frank, S., Adachi, K., Piccini, I., Quaranta, R., Araúzo-Bravo, M. J., Schwarz, J., Schade, D., Leidel, S. A., et al. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.11.019 · Cited by 117
“Conversely, directed cardiac differentiation protocols for hESCs tend to mimic the aforementioned sequence of events (Murry and Keller, 2008): they are based on an initial stimulation of at least one of themajor signaling pathways involved in gastrulation, notably BMP and/or WNT, followed by WNT inhibition as a second…”
BackgroundSahara, M., Hansson, E. M., Wernet, O., Lui, K. O., Später, D., & Chien, K. R. (2014) · Cell Research · doi:10.1038/cr.2014.59 · Cited by 110
Weng, Z., Kong, C.-W., Ren, L., Karakikes, I., Geng, L., He, J., Chow, M. Z. Y., Mok, C. F., Chan, H. Y. S., Webb, S. E., et al. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0509 · Cited by 109
“Given that most methods for directed cardiac differentiation reported to date require line-dependent optimizations of growth factors [1,3,4,15], we next tested the versatility of our protocol for consistent hPSC-VCM yields with different lines.”
InfluentialPromoting Mechanisms of Vascular Health
Moreno, P., Sanz, J., & Fuster, V. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.02.057 · Cited by 123
Large-scale production of human pluripotent stem cell derived cardiomyocytes
Kempf, H., Andree, B., & Zweigerdt, R. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.016 · Cited by 108
“[79] L. Yang, M.H. Soonpaa, E.D. Adler, T.K. Roepke, S.J. Kattman, M. Kennedy, E. Henckaerts, K. Bonham, G.W. Abbott, R.M. Linden, L.J. Field, G.M. Keller, Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cellderived population, Nature 453 (2008) 524–528.”
BackgroundJarrige, M., Frank, E., Herardot, E., Martineau, S., Darle, A., Benabidès, M., Domingues, S., Chose, O., Habeler, W., Lorant, J., et al. (2021) · Cells · doi:10.3390/cells10020240 · Cited by 117
Gastruloids enable modeling of the earliest stages of human cardiac and hepatic vascularization
Abilez, O. J., Yang, H., Guan, Y., Shen, M., Yıldırım, Z., Zhuge, Y., Venkateshappa, R., Zhao, S. R., Gomez, A. H., El‐Mokahal, M., et al. (2025) · Science · doi:10.1126/science.adu9375 · Cited by 111
cKit + cardiac progenitors of neural crest origin
Hatzistergos, K. E., Takeuchi, L. M., Saur, D., Seidler, B., Dymecki, S. M., Jia, J., White, I. A., Balkan, W., Kanashiro‐Takeuchi, R. M., Schally, A. V., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517201112 · Cited by 111
“Our findings confirm previous developmental studies in mice showing that, during gastrulation, cKit is expressed in extraembryonic mesoderm and embryonic ectoderm, but not mesodermal CPs (4, 13, 14, 42).”
BackgroundResultEvaluating the utility of cardiomyocytes from human pluripotent stem cells for drug screening
Dick, E., Rajamohan, D., Ronksley, J., & Denning, C. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381037 · Cited by 110
Lee, A. S., Xu, D., Plews, J. R., Nguyen, P. K. P., Nag, D., Lyons, J. K., Han, L., Hu, S., Lan, F., Liu, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.235739 · Cited by 107
Zakharova, L., Mastroeni, D., Mutlu, N., Molina, M., Goldman, S., Diethrich, E. B., & Gaballa, M. A. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq027 · Cited by 117
“KDR, kinase domain protein receptor, was recently identified as a marker for cardiovascular lineage progenitors in differentiating embryonic stem cells.(21) Here, we found that the c-Kitþ cells were also Nkx2.”
BackgroundWhite, M. P., Rufaihah, A. J., Liu, L., Ghebremariam, Y. T., Ivey, K. N., Cooke, J. P., & Srivastava, D. (2013) · Stem Cells · doi:10.1002/stem.1267 · Cited by 106
Rafii, S., Kloss, C. C., Butler, J. M., Ginsberg, M. D., Gars, E. J., Lis, R., Zhan, Q., Josipović, P., Ding, B., Xiang, J., et al. (2012) · Blood · doi:10.1182/blood-2012-07-444208 · Cited by 116
Matsa, E., Ahrens, J. H., & Wu, J. C. (2016) · Physiological Reviews · doi:10.1152/physrev.00036.2015 · Cited by 105
Primitive Cardiac Cells from Human Embryonic Stem Cells
Hudson, J., Titmarsh, D., Hidalgo, A., Wolvetang, E., & Cooper-White, J. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0254 · Cited by 103
“After the induction of primitive streak cells, cardiomyocyte differentiation was promoted by inhibition of Wnt signaling [20] using a small molecule inhibitor of Wnt production, IWP-4 (5 m M) [31].”
InfluentialGeneration of beta cells from human pluripotent stem cells: Potential for regenerative medicine
Nostro, M. C., & Keller, G. (2012) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2012.06.010 · Cited by 104
Self-citationOrgan‐On‐A‐Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies
Ahadian, S., Civitarese, R., Bannerman, D., Mohammadi, M. H., Lu, R., Wang, E., Davenport‐Huyer, L., Lai, B., Zhang, B., Zhao, Y., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201800734 · Cited by 95
Current status of drug screening and disease modelling in human pluripotent stem cells
Rajamohan, D., Matsa, E., Kalra, S., Crutchley, J., Patel, A., George, V., & Denning, C. (2013) · BioEssays · doi:10.1002/bies.201200053 · Cited by 99
Zhao, M., Tang, Y., Zhou, Y., & Zhang, J. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-55620-x · Cited by 109
Wickramasinghe, N. M., Sachs, D. M., Shewale, B., Gonzalez, D. M., Dhanan-Krishnan, P., Torre, D., LaMarca, E. A., Raimo, S., Dariolli, R., Serasinghe, M. N., et al. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.02.011 · Cited by 109
Cheung, C., Bernardo, A. S., Pedersen, R. A., & Sinha, S. (2014) · Nature Protocols · doi:10.1038/nprot.2014.059 · Cited by 105
Physiological aspects of cardiac tissue engineering
Eschenhagen, T., Eder, A., Vollert, I., & Hansen, A. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00007.2012 · Cited by 100
Efficient Generation and Cryopreservation of Cardiomyocytes Derived from Human Embryonic Stem Cells
Xu, C., Police, S., Hassanipour, M., Li, Y., Chen, Y., Priest, C., O‘Sullivan, C., Laflamme, M. A., Zhu, W.-Z., Van Biber, B., et al. (2011) · Regenerative Medicine · doi:10.2217/rme.10.91 · Cited by 101
Surface-patterned electrode bioreactor for electrical stimulation
Tandon, N. M., Marsano, A., Maidhof, R., Numata, K., Montouri-Sorrentino, C., Cannizzaro, C., Voldman, J., & Vunjak‐Novakovic, G. (2010) · Lab on a Chip · doi:10.1039/b917743d · Cited by 109
Cellular and Engineered Organoids for Cardiovascular Models
Thomas, D., Choi, S., Alamana, C., Parker, K. K., & Wu, J. C. (2022) · Circulation Research · doi:10.1161/circresaha.122.320305 · Cited by 105
BMP4 Promotes EMT and Mesodermal Commitment in Human Embryonic Stem Cells via SLUG and MSX2
Richter, A., Valdimarsdottir, L., Hrafnkelsdottir, H. E., Runarsson, J. F., Omarsdottir, A. R., Oostwaard, D. W.-V., Mummery, C., & Valdimarsdottir, G. (2014) · Stem Cells · doi:10.1002/stem.1592 · Cited by 98
Abbasalizadeh, S., & Baharvand, H. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.009 · Cited by 108
Carpenter, L., Carr, C., Yang, C. T., Stuckey, D. J., Clarke, K., & Watt, S. M. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0075 · Cited by 94
“It is unclear at this time whether these cells arise from the cardiac progenitor described by Yang and colleagues [27] or from a distinct progenitor that can form independently during differentiation, such as the hemangioblast [37].”
BackgroundMethodInfluentialHalloin, C., Schwanke, K., Löbel, W., Franke, A., Szepes, M., Biswanath, S., Wunderlich, S., Merkert, S., Weber, N., Osten, F., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.06.004 · Cited by 100
Current Stem Cell Delivery Methods for Myocardial Repair
Sheng, C. C., Zhou, L., & Hao, J. (2012) · BioMed Research International · doi:10.1155/2013/547902 · Cited by 110
Tan, J. Y., Sriram, G., Rufaihah, A. J., Neoh, K. G., & Cao, T. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0590 · Cited by 105
Cell Fate Potential of Human Pluripotent Stem Cells Is Encoded by Histone Modifications
Hong, S., Rampalli, S., Lee, J. B., McNicol, J. D., Collins, T., Draper, J. S., & Bhatia, M. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.06.002 · Cited by 98
“Using immunohistochemistry screens, we detected two markers, c-KIT and A2B5, previously associated with mesoderm progenitors and neural precursors, respectively (Carpenter et al., 2001; Yang et al., 2008).”
BackgroundInduced pluripotent stem cell-derived cardiomyocytes for drug development and toxicity testing
Sinnecker, D., Laugwitz, K., & Moretti, A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.03.004 · Cited by 101
“Therefore, it is important to understand the regulation of cardiac differentiation, an area in which substantial progress has been made during the past decade (Laflamme et al., 2007; Yang et al., 2008; Kattman et al., 2011; Burridge et al., 2012).”
BackgroundHuang, J., Sun, L., Mennigen, J. A., Liu, Y., Liu, S., Zhang, M., Wang, Q., & Tu, W. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.124491 · Cited by 101
Desai, S. P., Kohli, V., Kang, J., Chi, N. C., Black, B. L., & Sumanas, S. (2011) · Development · doi:10.1242/dev.064998 · Cited by 101
“…a growing body of evidence from multiple laboratories suggest that, with respect to lineage diversification, there may be a single stem/progenitor cell that can generate all major cell types during heart formation (Kattman et al., 2006; Moretti et al., 2006; Wu et al., 2006; Yang et al., 2008).”
BackgroundWilliams, I. M., & Wu, J. C. (2019) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.312265 · Cited by 91
“This suggests that ECs moving through a hemogenic mesodermal intermediate may be similar to ECs derived from HEPs and perhaps to hemogenic ECs.64 Alternatively, ECs derived from cardiogenic mesoderm may be more similar to the CVP-derived ECs described by Yang et al.47 Although ECs stemming from these different lineage…”
ResultGeometric Control of Cardiomyogenic Induction in Human Pluripotent Stem Cells
Bauwens, C. L., Song, H., Thavandiran, N., Ungrin, M., Massé, S., Nanthakumar, K., Séguin, C. A., & Zandstra, P. W. (2011) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0563 · Cited by 103
The electrophysiological development of cardiomyocytes
Liu, J., Laksman, Z., & Backx, P. H. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.023 · Cited by 106
Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies
Brandão, K. O., Tabel, V. A., Atsma, D. E., Mummery, C. L., & Davis, R. P. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.030320 · Cited by 106
“…protocols therefore focussed on generating cardiomyocytes from EBs containing defined numbers of cells, in serum-free medium with timed exposure to cytokines known to play a role in embryonic heart development (Burridge et al., 2011; Elliott et al., 2011; Kattman et al., 2011; Yang et al., 2008).”
BackgroundStem Cell-Based Therapeutic Applications in Retinal Degenerative Diseases
Huang, Y., Enzmann, V., & Ildstad, S. T. (2010) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9192-8 · Cited by 104
“Therefore, ESC hold great therapeutic promise in the generation of functional cell types relevant for neurons [30–34], cardiomyocytes [35, 36], hepatocytes [37], lung epithelium [38] and pancreatic beta cells [39, 40].”
Micropatterning of human embryonic stem cells dissects the mesoderm and endoderm lineages
Lee, L. H., Peerani, R., Ungrin, M., Joshi, C., Kumacheva, E., & Zandstra, P. W. (2008) · Stem Cell Research · doi:10.1016/j.scr.2008.11.004 · Cited by 112
“Although fluorescent reporter cell lines combined with cell sorting are powerful tools that have been used to isolate target cell types from mixed cell populations (Davis et al., 2008; Yang et al., 2008), better technologies for the generation of specific mesoderm- and endoderm-derived cells are needed.”
BackgroundMethodInfluentialFreund, C. M. A. H., & Mummery, C. L. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22164 · Cited by 108
“This ‘‘spontaneous’’ differentiation is now being replaced by addition of members of the transforming growth factor (TGF)-b superfamily (including bone morphogenetic proteins (BMPs) and activin as a surrogate to nodal) and of canonical Wnt signaling, which are essential for the specification of (cardiac) mesoderm [Yan…”
BackgroundInfluentialMultiscale Computational Models for Optogenetic Control of Cardiac Function
Abilez, O. J., Wong, J., Prakash, R., Deisseroth, K. A., Zarins, C. K., & Ellen Kuhl, A. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.08.004 · Cited by 94
Sasaki, D., Matsuura, K., Seta, H., Haraguchi, Y., Okano, T., & Shimizu, T. (2018) · PLOS ONE · doi:10.1371/journal.pone.0198026 · Cited by 91
Concise Review: Cell Therapy and Tissue Engineering for Cardiovascular Disease
Haraguchi, Y., Shimizu, T., Yamato, M., & Okano, T. (2012) · Stem Cells Translational Medicine · doi:10.5966/sctm.2011-0030 · Cited by 90
Olmer, R., Engels, L., Usman, A., Menke, S., Malik, M. N. H., Peßler, F., Göhring, G., Bornhorst, D., Bolten, S. N., Abdelilah‐Seyfried, S., et al. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.03.017 · Cited by 98
Cimetta, E., Cannizzaro, C., James, R., Biechele, T., Moon, R. T., Elvassore, N., & Vunjak-Novakovic, G. (2010) · Lab on a Chip · doi:10.1039/c0lc00033g · Cited by 88
Mehta, A. K., Chung, Y. Y., Ng, A., Iskandar, F., Atan, S., Wei, H., Dusting, G. J., Sun, W. Y., Wong, P., & SHIM, W. S. N. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr132 · Cited by 95
“current differentiation systems and protocols may be subjected to manipulations to trigger known cardio-mesoderm signalling pathways in an attempt to augment cardiomyocyte yield.(3,33)”
BackgroundMagadum, A., Ding, Y., He, L., Kim, T., Vasudevarao, M. D., Long, Q., Yang, K., Wickramasinghe, N., Renikunta, H. V., Dubois, N., et al. (2017) · Cell Research · doi:10.1038/cr.2017.84 · Cited by 87
Babiarz, J. E., Ravon, M., Sridhar, S., Ravindran, P., Swanson, B., Bitter, H., Weiser, T., Chiao, E., Certa, U., & Kolaja, K. L. (2012) · Stem Cells and Development · doi:10.1089/scd.2011.0357 · Cited by 93
“The differentiation of hiPSCs to cardiomyocytes has been reported by a number of groups and is perhaps the most well-studied hiPSC-derived tissue [11–14].”
BackgroundComes, S., Gagliardi, M., Laprano, N., Fico, A., Cimmino, A., Palamidessi, A., Cesare, D. D., Falco, S. D., Angelini, C., Scita, G., et al. (2013) · Stem Cell Reports · doi:10.1016/j.stemcr.2013.09.001 · Cited by 97
“L-Pro is particularly interesting because its mitochondrial oxida- Stem Cell tive catabolism is linked to cell survival/cell death in cancer cells (Liu et al., 2012; Phang et al., 2012) and to life span extension inC. elegans (Zarse et al., 2012).”
Animal and cellular models of Friedreich ataxia
Perdomini, M., Hick, A., Puccio, H. M., & Pook, M. A. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12219 · Cited by 103
“…toward the cardiac lineage may be improved by using recent promising protocols based on the sequential treatment of iPSCs with specific growth factors that are dedicated to mimic heart development (Yang et al. 2008; Kattman et al. 2011; Zhang et al. 2011b; Carpenter et al. 2012; Lian et al. 2012).”
BackgroundPluripotent Stem Cell Models of Human Heart Disease
Moretti, A., Laugwitz, K.-L., Dorn, T., Sinnecker, D., & Mummery, C. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014027 · Cited by 91
Zhang, M., Schulte, J. S., Heinick, A., Piccini, I., Rao, J., Quaranta, R., Zeuschner, D., Malan, D., Kim, K.-P., Röpke, A., et al. (2015) · Stem Cells · doi:10.1002/stem.1964 · Cited by 95
Yamamoto, Y., Makiyama, T., Harita, T., Sasaki, K., Wuriyanghai, Y., Hayano, M., Nishiuchi, S., Kohjitani, H., Hirose, S., Chen, J., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx073 · Cited by 95
“into cardiomyocytes using an EB differentiating system (25).”
MethodBhattacharya, S., Burridge, P. W., Kropp, E. M., Chuppa, S. L., Kwok, W.-M., Wu, J. C., Boheler, K. R., & Gundry, R. L. (2014) · Journal of Visualized Experiments · doi:10.3791/52010 · Cited by 83
Cardiac repair and regeneration: the Rubik’s cube of cell therapy for heart disease
Boudoulas, K. D., & Hatzopoulos, A. K. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.000240 · Cited by 101
High-purity enrichment of functional cardiovascular cells from human iPS cells
Lin, B., Kim, J. K., Li, Y., Pan, H., Carvajal‐Vergara, X., Salama, G., Cheng, T., Li, Y., Lo, C. W. Y., & Yang, L. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs185 · Cited by 90
“KDR, c-kit-negative MCPs, not from the high-KDR, high-c-kit or KDR-negative, high-c-kit population (see Supplementary material online, Movie S2), the same as described before.(3) Given that the day 6 low-KDR, c-kit-negative cells are a heterogeneous population containing MCPs at dynamic stages of heart development, th…”
BackgroundMethodSelf-citationMending a broken heart: current strategies and limitations of cell-based therapy
Liew, L. C., Ho, B. X., & Soh, B.-S. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01648-0 · Cited by 97
Irion, S., Nostro, M. C., Kattman, S. J., & Keller, G. M. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.065 · Cited by 83
“The identification of the cardiovascular progenitor in mESC cultures provided the basis for the identification of a comparable human progenitor (Yang et al. 2008).”
BackgroundSelf-citationParrotta, E. I., Lucchino, V., Scaramuzzino, L., Scalise, S., & Cuda, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124354 · Cited by 88
“Serum was later replaced by cytokines and growth factors known to be involved in heart development such as Wnt proteins [38], bone morphogenetic proteins (BMPs) and activin A [31,39], and Notch signals [40], together with their corresponding inhibitors [41,42].”
BackgroundProgramming and reprogramming a human heart cell
Sahara, M., Santoro, F., & Chien, K. R. (2015) · The EMBO Journal · doi:10.15252/embj.201490563 · Cited by 97
“This progenitor population, identified by low kinase insert domain receptor (KDR) expression and absence of c-kit, was able to give rise to more than 50% contracting cardiomyocytes (Yang et al , 2008).”
Myocardial regeneration: Roles of stem cells and hydrogels
Ye, Z., Zhou, Y., Cai, H., & Tan, W. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.02.007 · Cited by 95
Ting, S., Chen, A., Reuveny, S., & Oh, S. (2014) · Stem Cell Research · doi:10.1016/j.scr.2014.06.002 · Cited by 85
“Multiple protocols initiate CM differentiation through activation of the TGF-β pathway directly by addition of growth factors (Activin A and BMP4) (Burridge et al., 2011; Kattman et al., 2011; Yang et al., 2008; Willems et al., 2011) or indirectly with the addition of small molecules (CHIR or BIO) (Lian et al.”
BackgroundKeung, W., Boheler, K. R., & Li, R. A. (2014) · Stem Cell Research & Therapy · doi:10.1186/scrt406 · Cited by 87
“An improved protocol from Keller’s group, involving addition of low bone morphogenetic protein (BMP)4 levels during EB formation and the subsequent use of fibroblast growth factor 2, activin A, vascular endothelial growth factor A and dickkopf homolog 1, yields 70% of EBs with spontaneous contraction [6].”
MethodCardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery
Braam, S. R., Passier, R., & Mummery, C. L. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.001 · Cited by 86
Stem Cell Microenvironments ‐ Unveiling the Secret of How Stem Cell Fate is Defined
Votteler, M., Kluger, P. J., Walles, H., & Schenke‐Layland, K. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.201000102 · Cited by 102
Thomas, D., Cunningham, N. J., Shenoy, S., & Wu, J. C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab115 · Cited by 90
Chun, Y. W., Balikov, D. A., Feaster, T. K., Williams, C. H., Sheng, C. C., Lee, J.-B., Boire, T. C., Neely, M. D., Bellan, L. M., Ess, K. C., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.004 · Cited by 82
Developmental origin and lineage plasticity of endogenous cardiac stem cells
Santini, M. P., Forte, E., Harvey, R. P., & Kovacic, J. C. (2016) · Development · doi:10.1242/dev.111591 · Cited by 98
“Treatment of human ESC-derived embryoid bodies with BMP4, FGF2, VEGFA and dickkopf homolog 1 (DKK1) generated a VEGFR2low/ KIT− progenitor population with cardiomyocyte, endothelial cell and smoothmuscle cell potential in vitro and after transplantation (Yang et al., 2008).”
BackgroundHuman induced pluripotent stem cells are capable of B-cell lymphopoiesis
Carpenter, L., Malladi, R. K., Yang, C.-T., French, A., Pilkington, K. J., Forsey, R. W., Sloane‐Stanley, J., Silk, K. M., Davies, T. J., Fairchild, P. J., et al. (2011) · Blood · doi:10.1182/blood-2010-08-299941 · Cited by 84
Biowire platform for maturation of human pluripotent stem cell-derived cardiomyocytes
Sun, X., & Nunes, S. S. (2015) · Methods · doi:10.1016/j.ymeth.2015.11.005 · Cited by 90
Ding, S., Kingshott, P., Thissen, H. W., Pera, M. F., & Wang, P. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.26075 · Cited by 90
“Spontaneous differentiation and growth factor-based protocols have been established for generating myocytes (Laflamme et al., 2007; Yan et al., 2009; Yang et al., 2008).”
BackgroundHeart Regeneration with Engineered Myocardial Tissue
Coulombe, K. L. K., Bajpai, V. K., Andreadis, S. T., & Murry, C. E. (2014) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071812-152344 · Cited by 95
“cardiac mesoderm, reproducing the main elements of embryonic development (22, 23), and have been recently reviewed (24).”
BackgroundGeorge, V., Colombo, S., & Targoff, K. L. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.12.019 · Cited by 83
“Currently, protocols to convert ES and iPS cells into cardiomyocytes are being developed with improved rates of efficiency (Braam et al., 2009; Bu et al., 2009; Domian et al., 2009; Hansson et al., 2009; Lundy et al., 2013; Mercola et al., 2013; Murry and Keller, 2008; Yang et al., 2008).”
BackgroundZhao, Z., Lan, H., El‐Battrawy, I., Li, X., Buljubasic, F., Sattler, K., Yücel, G., Lang, S., Tiburcy, M., Zimmermann, W., et al. (2018) · Stem Cells International · doi:10.1155/2018/6067096 · Cited by 87
Developmental and Regenerative Biology of Multipotent Cardiovascular Progenitor Cells
Sturzu, A. C., & Wu, S. M. (2011) · Circulation Research · doi:10.1161/circresaha.110.227066 · Cited by 90
Notch signaling respecifies the hemangioblast to a cardiac fate
Chen, V. C., Stull, R. A., Joo, D., Cheng, X., & Keller, G. M. (2008) · Nature Biotechnology · doi:10.1038/nbt.1497 · Cited by 90
“developmental progression of the mesoderm subpopulations to their respective fates have led to the identification of distinct progenitor populations that display both tissue specific and vascular potential 4-10 .”
Self-citationLin, Y., Linask, K. L., Mallon, B., Johnson, K., Klein, M., Beers, J., Xie, W., Du, Y., Liu, C., Lai, Y., et al. (2017) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0428 · Cited by 80
Luna, J. I., Ciriza, J., Garcia-Ojeda, M. E., Kong, M., Herren, A., Lieu, D. K., Li, R. A., Fowlkes, C. C., Khine, M., & McCloskey, K. E. (2011) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2010.0410 · Cited by 80
“The hESC (WiCells) HES2 line (NIH code: ES02) was cultured under feeder-free conditions on hESC-qualified Matrigel (Becton Dickinson) in mTeSR (Stem Cell Technologies) and differentiated as described by Yang et al. 37 Briefly, hESCs were detached using trypsin (Invitrogen) and transferred to low-attachment plates to all…”
InfluentialHerrmann, F., Groß, A., Zhou, D., Kestler, H. A., & Kühl, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046798 · Cited by 79
“At this stage the cardiogenic mesoderm splits from a common cardiovascular progenitor cell population [1,2] into two areas of differential gene expression: the so-called first heart field (FHF) and the second heart field (SHF).”
BackgroundMethodKawaguchi, N., Smith, A. J., Waring, C. D., Hasan, M. K., Miyamoto, S., Matsuoka, R., & Ellison, G. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014297 · Cited by 85
“), and therefore cCSC-derived functional beating cardiomyocytes in our CSC/cardiomyocyte co-culture system. Indeed, similar to cardiomyogenic differentiation of embryonic stem cells”
BackgroundModulation of Wnt/β-catenin signaling in human embryonic stem cells using a 3-D microwell array
Azarin, S. M., Lian, X., Larson, E. A., Popelka, H. M., de Pablo, J. J., & Palecek, S. P. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.070 · Cited by 78
Human cardiomyocyte generation from pluripotent stem cells: A state-of-art
Talkhabi, M., Aghdami, N., & Baharvand, H. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.12.023 · Cited by 87
Metadata
- Authors
- Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., Field, L. J., & Keller, G. M.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Indiana University School of Medicine (US)
- Cornell University (US)
- University Health Network (CA)
- King's College London (GB)
- VistaGen Therapeutics (United States) (US)
- Corresponding author
- Keller, Gordon M.
- ORCID
- Venue
- Nature
- Published
- 2008-04-23
- Volume
- 453
- Issue
- 7194
- Pages
- 524-528
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2010417854
- Cited by
- 1,389
- References
- 30
- Citations by year
- 2026: 17 · 2025: 20 · 2024: 20 · 2023: 33 · 2022: 45 · 2021: 60 · 2020: 65 · 2019: 59 · 2018: 66 · 2017: 89 · 2016: 79 · 2015: 107 · 2014: 114 · 2013: 141 · 2012: 146
- FWCI
- 45.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lirias (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL079275, R01HL083126)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- human embryonic stem cells, cardiac progenitor cells, KDR, Flk-1, cardiomyocyte differentiation, endothelial differentiation, vascular smooth muscle cell differentiation, mesoderm specification, heart development, embryoid bodies, cell transplantation, cardiac regeneration, cardiovascular tissue engineering, lineage tracing, clonal origin, growth factor cocktail, activin A, BMP4, basic fibroblast growth factor
- MeSH terms
- Cell Differentiation, Cell Line, Humans, Fibroblast Growth Factor 2, Patch-Clamp Techniques, Proto-Oncogene Proteins c-kit, Cell Lineage, Bone Morphogenetic Proteins, Activins, Myocytes, Cardiac, Intercellular Signaling Peptides and Proteins, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Embryonic Stem Cells, Bone Morphogenetic Protein 4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.